ClinicalTrials.gov
public full text
Public Domain
Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis
The purpose of this study is to investigate the utility of a continuous glucose monitor device (CGM) in screening for cystic fibrosis related diabetes. The investigators will also study how fat deposition in the pancreas and liver impacts insulin production and response, as measured by a frequently sampled oral glucose tolerance test.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Use of Home Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes#257047
- Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis.#1007768
- Surveillance of Pancreatic Health After Diabetes Diagnosis#162399
- Cystic Fibrosis Related Diabetes Screening.#1322931
- Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities#835991
Record · ID 1410903
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive